- Citations, last 5 years
- 68
- Works, last 5 years
- 10
- h-index
- 54
- Scientists listed
- 0
- Grants since 2016
- 8
Grants received
2024–2025 · research · R43
Improving survival from Burkholderia pseudomallei and other pathogenic intracellular bacteria
George Norbert Cox · Bolder Biotechnology, Inc. · funded by National Institutes of Health
2023–2025 · contract · N01
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
George Cox · Bolder Biotechnology, Inc. · funded by National Institutes of Health
2023–2024 · contract · N01
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
George Cox · Bolder Biotechnology, Inc. · funded by National Institutes of Health
2021–2022 · research · R43
Stimulating innate immunity to protect against Ebola virus infection
George Norbert Cox · Bolder Biotechnology, Inc. · funded by National Institutes of Health
2019–2025 · research · R44
Novel drug combinations for improving survival from acute radiation syndrome when administered 48 hours post- irradiation
George Norbert Cox · Bolder Biotechnology, Inc. · funded by National Institutes of Health
2019–2021 · research · R43
Novel drugs combinations for improving survival from Acute Radiation Syndrome when administered 48h postirradiation
George Norbert Cox · Bolder Biotechnology, Inc. · funded by National Institutes of Health
2019–2026 · research · R44
Novel drug combinations for improving survival from acute radiation syndrome when administered 48 hours post- irradiation
George Norbert Cox · Bolder Biotechnology, Inc. · funded by National Institutes of Health
2019–2021 · research · R43
Novel drugs combinations for improving survival from Acute Radiation Syndrome when administered 48h postirradiation
George Norbert Cox · Bolder Biotechnology, Inc. · funded by National Institutes of Health